Considerable efforts have been exerted to implement Pharmacogenomics (PGx), the study
of interindividual variations in DNA sequence related to drug response, into routine clinical …

The continuous development of new genotyping technologies requires awareness of their
potential advantages and limitations concerning utility for pharmacogenomics (PGx). In this …

Conventional medicines optimisation interventions in people with multimorbidity and
polypharmacy are complex and yet limited; a more holistic and integrated approach to …

Surgical site infections (SSIs) remain a significant concern in the field of surgery, contributing
to patient morbidity, prolonged hospital stays, and increased healthcare costs. Antibiotic …

Introduction: Pharmacogenomic testing can indicate which drugs may have limited
therapeutic action or lead to adverse effects, hence guiding rational and safe prescribing …

Genetic factors have long been recognized as important determinants of interindividual
variability in drug efficacy and toxicity. However, despite the increasing number of …

With increasing patient interest in and access to pharmacogenomic testing, clinicians
practicing in primary care are more likely than ever to encounter a patient seeking or …

Abstract Introduction Pharmacogenomics (PGx) testing services have been delivered
through community pharmacies across the globe, though not yet in the UK. This paper is …

Pharmacogenetic studies the influence of inherited characteristics on medication. While
different from pharmacogenomics, which is a study of the entire genome in relation to …

Pharmacogenomics has been at the forefront of precision medicine during the last few
decades. Precision medicine carries the potential of improving health outcomes at both the …